2m 2m 2m 2m 2m 2m 2m
SAB BIOTHERAP (SABS)
NASDAQ
$3.85+$0.12 (+3.32%)
Price as of Jul 14, 2026 7:00 AM EDT- $285.2MMarket Cap
- 38.66%1-Year Change
- BiotechnologyIndustry
SAB BIOTHERAP (SABS)
$3.85+$0.12 (+3.32%)
Earnings Score
No data found
Momentum Score
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -11.26% | ||
12-Month Momentum | 27.31% | ||
3-Month Risk Adjusted Momentum | -40.92% | ||
12-Month Risk Adjusted Momentum | 36.22% |
True Yield
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.60% |
Financial Health Score
No data found